dc.contributor.author |
ElHajj I. |
dc.contributor.author |
Uthman I. |
dc.contributor.author |
Chahel A. |
dc.contributor.author |
Khoury F. |
dc.contributor.author |
Arayssi T. |
dc.contributor.author |
Taher A. |
dc.contributor.editor |
|
dc.date |
Nov-2004 |
dc.date.accessioned |
2017-10-05T15:40:51Z |
dc.date.available |
2017-10-05T15:40:51Z |
dc.date.issued |
2004 |
dc.identifier |
10.1191/0961203303lu1059cr |
dc.identifier.isbn |
|
dc.identifier.issn |
09612033 |
dc.identifier.uri |
http://hdl.handle.net/10938/17686 |
dc.description.abstract |
Familial clustering of elevated antiphospholipid antibody levels has been described, but the reports are heterogeneous with regard to the characterization of the antiphospholipid syndrome (APS), coexisting autoimmune diseases and clinical implications. We report a familial occurrence of APS in two patients, in the presence of SLE in the mother and absence of autoimmune diseases in the daughter along with acquired circulating inhibitors in both cases: platelet inhibitor and factor IX inhibitor, respectively. |
dc.format.extent |
|
dc.format.extent |
Pages: (812-814) |
dc.language |
English |
dc.publisher |
LONDON |
dc.relation.ispartof |
Publication Name: Lupus; Publication Year: 2004; Volume: 13; no. 10; Pages: (812-814); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Familial antiphospholipid antibodies and acquired circulating anticoagulants |
dc.type |
Article |
dc.contributor.affiliation |
ElHajj, I., Department of Internal Medicine, Amer. Univ. Beirut Med. Ctr. (AUBMC), Beirut, Lebanon |
dc.contributor.affiliation |
Uthman, I., Division of Rheumatology, Amer. Univ. Beirut Med. Ctr. (AUBMC), Beirut, Lebanon |
dc.contributor.affiliation |
Chahel, A., Division of Hematology-Oncology, Amer. Univ. Beirut Med. Ctr. (AUBMC), Beirut, Lebanon |
dc.contributor.affiliation |
Khoury, F., Department of Internal Medicine, Amer. Univ. Beirut Med. Ctr. (AUBMC), Beirut, Lebanon |
dc.contributor.affiliation |
Arayssi, T., Division of Rheumatology, Amer. Univ. Beirut Med. Ctr. (AUBMC), Beirut, Lebanon |
dc.contributor.affiliation |
Taher, A., Division of Hematology-Oncology, Amer. Univ. Beirut Med. Ctr. (AUBMC), Beirut, Lebanon, Department of Internal Medicine, Amer. Univ. of Beirut Medical Center, Hamra street, Beirut 1107 2802, Lebanon |
dc.contributor.authorAddress |
Taher, A.; Department of Internal Medicine, Amer. Univ. of Beirut Medical Center, Hamra street, Beirut 1107 2802, Lebanon; email: ataher@aub.edu.lb |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine; |
dc.contributor.authorDepartment |
Internal Medicine |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
ataher@aub.edu.lb |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
ElHajj, I |
dc.contributor.authorInitials |
Uthman, I |
dc.contributor.authorInitials |
Chahel, A |
dc.contributor.authorInitials |
Khoury, F |
dc.contributor.authorInitials |
Arayssi, T |
dc.contributor.authorInitials |
Taher, A |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Taher, A (reprint author), Amer Univ Beirut, Med Ctr, Dept Internal Med, Hamra St, Beirut 1107 2802, Lebanon. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
ARNETT FC, 1991, J CLIN INVEST, V87, P1490, DOI 10.1172-JCI115158; ASHERSON RA, 1992, ARTHRITIS RHEUM, V35, P142; CASTRO O, 1972, ANN INTERN MED, V77, P543; EXNER T, 1980, BRIT J HAEMATOL, V45, P89, DOI 10.1111-j.1365-2141.1980.tb03814.x; GASTINEAU DA, 1985, AM J HEMATOL, V19, P265, DOI 10.1002-ajh.2830190308; GOLDBERG SN, 1995, AM J MED, V99, P473, DOI 10.1016-S0002-9343(99)80222-8; HASSELAAR P, 1989, ANN RHEUM DIS, V48, P933, DOI 10.1136-ard.48.11.933; LARGO R, 1974, BRIT J HAEMATOL, V26, P129, DOI 10.1111-j.1365-2141.1974.tb00456.x; MILLER K, 1978, J PEDIATR, V93, P232, DOI 10.1016-S0022-3476(78)80502-2; ORLANDO E, 1992, THROMB HAEMOSTASIS, V68, P495; SHAPIRO S S, 1975, Seminars in Thrombosis and Hemostasis, V1, P336 |
dc.description.citedCount |
3 |
dc.description.citedTotWOSCount |
2 |
dc.description.citedWOSCount |
1 |
dc.format.extentCount |
3 |
dc.identifier.articleNo |
|
dc.identifier.coden |
LUPUE |
dc.identifier.pubmedID |
15540515 |
dc.identifier.scopusID |
7644243106 |
dc.identifier.url |
|
dc.publisher.address |
338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Lupus |
dc.relation.ispartOfIssue |
10 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Lupus |
dc.relation.ispartofPubTitleAbbr |
Lupus |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
13 |
dc.source.ID |
WOS:000224835100009 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
Factor IX inhibitor |
dc.subject.otherAuthKeyword |
Familial antiphospholipid syndrome |
dc.subject.otherAuthKeyword |
Platelet inhibitor |
dc.subject.otherAuthKeyword |
Prolonged bleeding time |
dc.subject.otherChemCAS |
blood clotting factor 9, 9001-28-9 |
dc.subject.otherChemCAS |
cyclophosphamide, 50-18-0 |
dc.subject.otherChemCAS |
hydroxychloroquine, 118-42-3, 525-31-5 |
dc.subject.otherChemCAS |
prednisone, 53-03-2 |
dc.subject.otherChemCAS |
Antibodies |
dc.subject.otherChemCAS |
Antibodies, Antiphospholipid |
dc.subject.otherChemCAS |
circulating anticoagulants |
dc.subject.otherChemCAS |
Factor IX, 9001-28-9 |
dc.subject.otherChemCAS |
Immunoglobulins |
dc.subject.otherChemCAS |
Platelet Aggregation Inhibitors |
dc.subject.otherIndex |
anticoagulant agent |
dc.subject.otherIndex |
antinuclear antibody |
dc.subject.otherIndex |
blood clotting factor 9 |
dc.subject.otherIndex |
blood clotting factor 9 inhibitor |
dc.subject.otherIndex |
cyclophosphamide |
dc.subject.otherIndex |
DNA antibody |
dc.subject.otherIndex |
double stranded DNA |
dc.subject.otherIndex |
hydroxychloroquine |
dc.subject.otherIndex |
immunosuppressive agent |
dc.subject.otherIndex |
phospholipid antibody |
dc.subject.otherIndex |
prednisone |
dc.subject.otherIndex |
protein inhibitor |
dc.subject.otherIndex |
thrombocyte slowing factor |
dc.subject.otherIndex |
unclassified drug |
dc.subject.otherIndex |
adult |
dc.subject.otherIndex |
antiphospholipid syndrome |
dc.subject.otherIndex |
arthritis |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
brain angiography |
dc.subject.otherIndex |
case report |
dc.subject.otherIndex |
clinical feature |
dc.subject.otherIndex |
comorbidity |
dc.subject.otherIndex |
confusion |
dc.subject.otherIndex |
diagnostic imaging |
dc.subject.otherIndex |
familial disease |
dc.subject.otherIndex |
female |
dc.subject.otherIndex |
follow up |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
immunosuppressive treatment |
dc.subject.otherIndex |
magnetic resonance angiography |
dc.subject.otherIndex |
memory disorder |
dc.subject.otherIndex |
partial thromboplastin time |
dc.subject.otherIndex |
photosensitivity |
dc.subject.otherIndex |
priority journal |
dc.subject.otherIndex |
proteinuria |
dc.subject.otherIndex |
rash |
dc.subject.otherIndex |
symptom |
dc.subject.otherIndex |
systemic lupus erythematosus |
dc.subject.otherIndex |
Adult |
dc.subject.otherIndex |
Antibodies |
dc.subject.otherIndex |
Antibodies, Antiphospholipid |
dc.subject.otherIndex |
Antiphospholipid Syndrome |
dc.subject.otherIndex |
Factor IX |
dc.subject.otherIndex |
Female |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Immunoglobulins |
dc.subject.otherIndex |
Lupus Erythematosus, Systemic |
dc.subject.otherIndex |
Middle Aged |
dc.subject.otherIndex |
Platelet Aggregation Inhibitors |
dc.subject.otherKeywordPlus |
FACTOR-IX INHIBITOR |
dc.subject.otherKeywordPlus |
LUPUS ANTICOAGULANT |
dc.subject.otherWOS |
Rheumatology |